SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FIIs raise stake in Cadila Healthcare in Q2FY15

16 Oct 2014 Evaluate

Foreign institutional investors (FIIs) have increased their stake in Cadila Healthcare by 45 basis points to 6.38 percent in Q2FY15 from 5.93 percent as on June 30, 2014. However, domestic institutional investors (DIIs) have reduced their shareholding in the company by 13 basis points to 8.13 percent at the end of September 2014 from 8.26 percent as on June 30, 2014.

Meanwhile, non institutions were holding 10.70 percent stake at the end of September 2014, down 32 basis points from 11.02 percent as on June 30, 2014, while corporate bodies were holding 4.67 percent stake at the end of September 2014, down 14 basis points from 4.81 percent as on June 30, 2014. Further, promoters’ holding was unchanged at 74.79 percent at the end of September 2014.

Zydus Lifesciences Share Price

929.95 -17.15 (-1.81%)
24-Apr-2026 11:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1624.95
Dr. Reddys Lab 1315.35
Cipla 1286.75
Zydus Lifesciences 929.95
Lupin 2272.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×